Last updated 3 months ago

Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies

35 patients around the world
Available in Mexico
This is an open-label study to provide continued access to treatment for eligible participants who continue to derive clinical benefit as determined by the investigator from study intervention(s) in a Pfizer-sponsored palbociclib clinical study (Parent Study)
Pfizer
1Research sites
35Patients around the world

This study is for people with

Head and neck cancer
Breast Cancer

Requirements for the patient

From 18 Years
All Gender

Medical requirements

Sites

Universidad Autónoma de Nuevo León, Hospital Universitario Dr. José Eleuterio González
Universidad Autónoma de Nuevo León, Hospital Universitario Dr. José Eleuterio González
Recruiting
Av. Madero y Gonzalitos S/N, Mitras Centro, Monterrey, Nuevo León
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy